|Articles|December 23, 2022

In Case You Missed It: The Week's Top Infectious Disease Stories

Author(s)Nina Cosdon

A new monoclonal antibody, invasive group A strep, and genital herpes topped the list of this week's most-read stories.

1. Bivalent Booster Provides Protection Against Severe COVID-19, Possible Hospitalization

In a new CDC report, these immunizations aid against emergency department and urgent care encounters in immunocompetent adults.

2. Invasive Strep A Cases Increase in the US, Internationally

The Centers for Disease Control and Prevention (CDC) is looking into the possibility of this rare group of infections emerging.

3. Economic Impact of Genital Herpes Indicates Developing a Vaccine Should Be Top Priority

Genital herpes (HSV-2) affects quality-of-life but also causes substantial economic losses, especially in low- and middle-income countries.

4. Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy

Virax Biolabs has developed a T-cell testing platform to develop an immune risk profile against viral threats.

5. FDA Approves Monoclonal for COVID-19 Treatment in Hospitalized Adults

Roche’s Actemra is the first FDA approved monoclonal antibody to be used for COVID-19.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.